Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule

NCT00572000 is registered in ClinicalTrials.gov with National Institute for Control of Vaccine and Biologicals as lead sponsor.

NCT NCT00572000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00572000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule
Lead sponsor
National Institute for Control of Vaccine and Biologicals
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2007
Completion date
June 30, 2008
Enrollment
222 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus (hpv) vaccine